Abstract
Autoimmune hypophysitis induced by Anti-PD-1 Monoclonal Antibody, Nivolumab and anticytotoxic T-lymphocyte antigen-4 (CTLA-4) agent, Ipilimumab, presenting by compressive symptoms and treated with intravenous methyl-prednisolone
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
